The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma
Authors
Keywords
-
Journal
CELLULAR ONCOLOGY
Volume 44, Issue 4, Pages 907-916
Publisher
Springer Science and Business Media LLC
Online
2021-06-25
DOI
10.1007/s13402-021-00610-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA 885-5p Inhibits Hepatocellular Carcinoma Metastasis by Repressing AEG1
- (2020) Cong Li et al. OncoTargets and Therapy
- Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer Cells
- (2019) Jiankun Gao et al. Molecular Therapy-Oncolytics
- Lnc‐ RMRP is involved in the progression of cholangiocarcinoma by regulating miR‐217
- (2019) Lingyu Tang et al. CANCER SCIENCE
- miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer
- (2019) Emmy Borgmästars et al. BMC BIOINFORMATICS
- MiR-885-5p Negatively Regulates Warburg Effect by Silencing Hexokinase 2 in Liver Cancer
- (2019) Fei Xu et al. Molecular Therapy-Nucleic Acids
- Arsenic circumvents the gefitinib resistance by binding to P62 and mediating autophagic degradation of EGFR in non-small cell lung cancer
- (2018) Jianhua Mao et al. Cell Death & Disease
- MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma
- (2017) Hao Li et al. HEPATOLOGY
- MicroRNA-212 targets FOXA1 and suppresses the proliferation and invasion of intrahepatic cholangiocarcinoma cells
- (2017) Lei Zhu et al. Experimental and Therapeutic Medicine
- TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures
- (2017) Anna Maria Lustri et al. PLoS One
- Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells
- (2016) Shunhua Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas
- (2016) Karen A. Boehme et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer
- (2016) Neveen Abd El Moneim Hussein et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma
- (2016) Xing Bao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study
- (2016) S. Modak et al. JOURNAL OF NUCLEAR MEDICINE
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
- (2016) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines
- (2015) YUAN-YUAN ZHAO et al. Molecular Medicine Reports
- The Generation of Insulin Producing Cells from Human Mesenchymal Stem Cells by MiR-375 and Anti-MiR-9
- (2015) Arefeh Jafarian et al. PLoS One
- Arsenic Trioxide Inhibits CXCR4-Mediated Metastasis by Interfering miR-520h/PP2A/NF-κB Signaling in Cervical Cancer
- (2014) Yi-Wen Chang et al. ANNALS OF SURGICAL ONCOLOGY
- Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9
- (2014) Marcos A. Muñiz Lino et al. Journal of Proteomics
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model
- (2013) Eun-Young Kim et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms
- (2011) Dianfeng Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival
- (2011) E A Afanasyeva et al. CELL DEATH AND DIFFERENTIATION
- Serum microRNA characterization identifiesmiR-885-5pas a potential marker for detecting liver pathologies
- (2010) Junhao Gui et al. CLINICAL SCIENCE
- Arsenic Trioxide Inhibits Cholangiocarcinoma Cell Growth and induces Apoptosis
- (2009) Fei Zhong et al. PATHOLOGY & ONCOLOGY RESEARCH
- Nuclear Co-translocation of Myotrophin and p65 Stimulates Myocyte Growth
- (2008) Biswajit Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search